BIOSUIS ParvoEry, Suspension for injection
BIOSUIS ParvoEry, Suspension for injection
Authorised
- Porcine parvovirus, strain CAPM V198 S-27, Inactivated
- Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
Product identification
Medicine name:
BIOSUIS ParvoEry, Suspension for injection
FIXR Parvo Ery Suspensie voor injectie
FIXR Parvo Ery Suspension injectable
FIXR Parvo Ery Injektionssuspension
Active substance:
- Porcine parvovirus, strain CAPM V198 S-27, Inactivated
- Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
Target species:
-
Pig (sow)
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Porcine parvovirus, strain CAPM V198 S-27, Inactivated4.00log2 haemagglutination inhibiting unit(s)1.00Dose
-
Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated1.00relative potency1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Pig (sow)
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AL01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Glass Vial 1 x 10.0 millilitre(s)
- Glass Vial 10 x 10.0 millilitre(s)
- Glass Vial 1 x 50.0 millilitre(s)
- Plastic Vial 1 x 50.0 millilitre(s)
- Glass Vial 1 x 100.0 millilitre(s)
- Plastic Vial 1 x 100.0 millilitre(s)
- Plastic Vial 1 x 250.0 millilitre(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- n.a.
Date of authorisation status change:
Reference member state:
-
Czechia
Procedure number:
- CZ/V/0148/001
Concerned member states:
-
Belgium
-
Bulgaria
-
Croatia
-
Denmark
-
Estonia
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Latvia
-
Lithuania
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: